In a survey of 400 respondents examining corporate R&D spending in 10 Central European countries (Croatia, Czech Republic, Estonia, Hungary, Lithuania, Latvia, Poland, Romania, Slovakia, Slovenia), 45% of companies plan to increase R&D spending in the next 1–2 years, and 57% plan to increase it in the next 3–5 years. Respondents in Slovakia, Croatia and […]

Globally, IPOs in the biotechnology industry have slowed in the first quarter; however, biotech venture capital (VC) in the UK has remained strong since 2015, accounting for 27%, or £178 million ($201.8 million), of the EU’s total biotech VC financing. In 2015, £489 million was raised in VC, a 51.4% increase. The 2015 trend of […]